PlainRecalls
FDA Drug Moderate Class II Terminated

ARIPIPRAZOLE TABLETS, 15 mg, 30-count. bottles, Rx Only, GSMS Incorporated, Manufactured by: Apotex Inc. Toronto, Ontario, Canada, Packaged by GSMS, Incorporated, Camarillo, CA 93012 USA, NDC #60429-449-30

Reported: December 9, 2020 Initiated: November 17, 2020 #D-0112-2021

Product Description

ARIPIPRAZOLE TABLETS, 15 mg, 30-count. bottles, Rx Only, GSMS Incorporated, Manufactured by: Apotex Inc. Toronto, Ontario, Canada, Packaged by GSMS, Incorporated, Camarillo, CA 93012 USA, NDC #60429-449-30

Reason for Recall

FAILED DISSOLUTION SPECIFICATIONS: Possibility of out-of-specification (OOS) dissolution limits for the remaining shelf life of the Aripiprazole Tablets

Details

Units Affected
11,922 bottles
Distribution
Distributed Nationwide in the USA
Location
Camarillo, CA

Frequently Asked Questions

What product was recalled?
ARIPIPRAZOLE TABLETS, 15 mg, 30-count. bottles, Rx Only, GSMS Incorporated, Manufactured by: Apotex Inc. Toronto, Ontario, Canada, Packaged by GSMS, Incorporated, Camarillo, CA 93012 USA, NDC #60429-449-30. Recalled by Golden State Medical Supply Inc.. Units affected: 11,922 bottles.
Why was this product recalled?
FAILED DISSOLUTION SPECIFICATIONS: Possibility of out-of-specification (OOS) dissolution limits for the remaining shelf life of the Aripiprazole Tablets
Which agency issued this recall?
This recall was issued by the FDA Drug on December 9, 2020. Severity: Moderate. Recall number: D-0112-2021.